By Professor Stephen John Kerr

Journal articles

Kerr SJ; Rowett DS; Sayer GP; Whicker SD; Saltman DC; Mant A, 2011, 'All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: A longitudinal study', British Journal of Clinical Pharmacology, 71, pp. 936 - 942, http://dx.doi.org/10.1111/j.1365-2125.2010.03702.x

Edwards-Jackson N; Kerr SJ; Tieu HV; Ananworanich J; Hammer SM; Ruxrungtham K; Phanuphak P; Avihingsanon A, 2011, 'Cardiovascular risk assessment in persons with HIV infection in the developing world: Comparing three risk equations in a cohort of HIV-infected Thais', HIV Medicine, 12, pp. 510 - 515, http://dx.doi.org/10.1111/j.1468-1293.2011.00916.x

Schneider K; Puthanakit T; Kerr SJ; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP, 2011, 'Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings', AIDS, 25, pp. 1143 - 1151, http://dx.doi.org/10.1097/QAD.0b013e3283466fab

Ananworanich J; Kerr SJ; Vernazza P; Mangclaviraj S; Chaithongwongwatthana S; Chotnopparatpattara P; Mahanontharit A; Ubolyam S; Jupimai T; Cooper DA; Ruxrungtham K; Hirschel B, 2011, 'Genital shedding of HIV after scheduled treatment interruption', International Journal of STD and AIDS, 22, pp. 61 - 66

Bunupuradah T; Puthanakit T; Kosalaraksa P; Kerr SJ; Boonrak P; Prasitsuebsai W; Lumbiganon P; Mengthaisong T; Phasomsap C; Pancharoen C; Ruxrungtham K; Ananworanich J, 2011, 'Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children', AIDS Research and Therapy, 8, pp. 40

Ramautarsing RA; van der Lugt J; Gorowara M; Kerr SJ; Burger D; Ruxrungtham K; Phanuphak P; Chaithongwongwatthana S; Avihingsanon A; Phanuphak N, 2011, 'Thai HIV-1 infected women do not require dose increase of lopinavir/ritonavir during the third trimester of pregnancy', AIDS, 25, pp. 1200 - 1303

Kerr SJ; Ananworanich J; Ruxrungtham K, 2010, 'Changing evidence on HIV treatment and prevention strategies: Implications and advice for healthcare workers and National Treatment Programs in Asia', Asian Biomedicine, 4, pp. 501 - 503

Wongsawat J; Puthanakit T; Kanjanavanit S; Hansudewechakul R; Ngampiyaskul C; Kerr SJ; Ubolyam S; Suwanlerk T; Kosalaraksa P; Luesomboon W; Ngo-Giang-Huong N; Chandara M; Saphonn V; Ruxrungtham K; Ananworanich J, 2010, 'CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children', Pediatric Infectious Disease Journal, 29, pp. 966 - 968, http://dx.doi.org/10.1097/INF.0b013e3181e0554c

Hemachandra A; Puls R; Sirivichayakul S; Kerr SJ; Thantiworasit P; Ubolyam S; Cooper DA; Emery S; Phanuphak P; Kelleher AD; Ruxrungtham K, 2010, 'An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection', Human Vaccines, 6, pp. 835 - 840

Bunupuradah T; Suntarattiwong P; Suntarattiwong P; Li AH; Sirivichayakul S; Pancharoen C; Boonrak P; Puthanakit T; Kerr SJ; Ruxrungtham K; Chotpitayasunondh T; Hirschel B; Ananworanich J, 2010, 'Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors', International Journal of Infectious Diseases, 14, pp. e311 - e316

Edwards‐Jackson N; Kerr SJ; Tieu HV; Ananworanich J; Hammer SM; Ruxrungtham K; Phanuphak P; Avihingsanon A, 2010, 'Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV‐infected Thais', Journal of the International AIDS Society, 13, http://dx.doi.org/10.1186/1758-2652-13-s4-o40

Wongsawat J; Puthanakit T; Kanjanavanit S; Hansudewechakul R; Ngampiyasakul C; Kerr SJ; Ubolyam S; Suwanlerk T; Kosalaraksa P; Luesomboon W; Ngo-Giang-Huong N; Chandara M; Sapphon V; Ruxrungtham K; Ananworanich J, 2010, 'CD4 cell count criteria to determine when to initiate antiretroviral therapy in children', Pediatric Infectious Disease Journal, 29, pp. 966 - 968

Duncombe CJ; Kerr SJ; Liddy J; Avihingsanon A; Ruxrungtham K; Phanuphak P, 2010, 'Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 54, pp. e19 - e20

Avihingsanon A; Apornpong T; Kerr SJ; Ananworanich J; Ruxrungtham K, 2010, 'Long‐term efficacy and safety of low‐dose ritonavir‐boosted atazanavir (ATV/r) 200/100 mg in HIV‐infected Thai patients', Journal of the International AIDS Society, 13, http://dx.doi.org/10.1186/1758-2652-13-s4-p60

Hemachandra A; Puls RL; Kerr SJ; Saengthong N; Pussadee K; Emery S; Phanuphak P; Ruxrungtham K, 2009, 'P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand', Retrovirology, 6, pp. P202, http://dx.doi.org/10.1186/1742-4690-6-S3-P202

Kerr S; Phanuphak P, 2009, 'An Asian perspective on HIV/AIDS', Asian Biomedicine, 3, pp. 9 - 14

Puthanakit T; Kerr SJ; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana V, 2009, 'Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy', Pediatric Infectious Disease Journal, 28, pp. 488 - 492, http://dx.doi.org/10.1097/INF.0b013e318194eea6

Risica PM; Kerr S; Lawson E; Belhumeur R; Ankoma A, 2009, 'Self-report of sugar-sweetened beverage and fast food consumption by annual household income.', Medicine and Health Rhode Island, 92, pp. 63 - 64

Avihingsanon A; van der Lugt J; Kerr SJ; Gorowara M; Chanmano S; Ohata P; Lange J; Cooper DA; Phanuphak P; Burger DM; Ruxrungtham K, 2009, 'A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults', Clinical Pharmacology and Therapeutics, 85, pp. 402 - 408

Kerr SJ; Phanuphak P, 2009, 'An Asian perspective on HIV/AIDS', Asian Biomedicine, 3, pp. 9 - 14

Puthanakit T; Kerr SJ; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana T, 2009, 'Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy', Pediatric Infectious Disease Journal, 28, pp. 488 - 492, http://dx.doi.org/10.1097/INF0b13e31894eea6

van der Lugt J; Gorowara M; Avihingsanon A; Burger D; Ananworanich J; Sringam K; wit F; Kerr SJ; Lange JM; Ruxrungtham K, 2009, 'Reducing the boosting dose of ritonavir does not affect saquinavir levels in HIV-infected individuals', AIDS, 23, pp. 1176 - 1179, http://www.ncbi.nlm.nih.gov/pubmed/19451794

Liddy JC; Duncombe C; Kerr SJ; Chapman RS, 2008, 'GENDER DIFFERENCES IN BASELINE CHARACTERISTICS AND VIROLOGICAL RESPONSE IN ANTIRETROVIRAL-NAIVE HIV PATIENTS IN THAILAND COMMENCING HAART', JOURNAL OF HEALTH RESEARCH, 22, pp. 15 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000453182700004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Layton MR; Kerr SJ; Chetchotisakd P, 2008, 'IMPACT OF PATIENT-HEALTH CARE PROVIDER COMMUNICATION: THE HIV/AIDS PATIENTS' PERSPECTIVES', VALUE IN HEALTH, 11, pp. A442 - A443, http://dx.doi.org/10.1016/S1098-3015(10)66490-X

Layton MR; Chadbunchachai S; Kerr SJ, 2008, 'PAIN MANAGEMENT IN THAILAND: IMPLICATION FOR BETTER PATIENT EDUCATION', VALUE IN HEALTH, 11, pp. A646 - A647, http://dx.doi.org/10.1016/S1098-3015(10)67105-7

Avihingsanon A; van der Lugt J; Kerr S; Gorowara M; Chanmano S; Cooper DA; Phanuphak P; Burger D; Ruxrungtham K, 2008, 'Impact of age on pharmacokinetics of boosted atazanavir 300/100 in Thai HIV-infected patients', Journal of the International AIDS Society, 11, pp. P244 - P244, http://dx.doi.org/10.1186/1758-2652-11-s1-p244

Mangclaviraj S; Kerr SJ; Chaithongwongwatthana S; Ananworanich J; Hirschel B; Emery S; Cooper DA; Chotnopparatpattara P; Ruxrungtham K; Phanuphak P, 2008, 'Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting', International Journal of STD and AIDS, 19, pp. 529 - 532

Corno AF; Ladusans EJ; Pozzi M; Kerr S, 2007, 'FloWatch versus conventional pulmonary artery banding', Journal of Thoracic and Cardiovascular Surgery, 134, pp. 1413 - 1420, http://dx.doi.org/10.1016/j.jtcvs.2007.03.065

Safreed-Harmon K; Siripong A; Kerr SJ; Gruskin S; Pancharoen C; Ananworanich J, 2007, 'Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents', CLINICAL INFECTIOUS DISEASES, 45, pp. 669 - 670, http://dx.doi.org/10.1086/520784

Safreed-Harmon K; Siripong A; Kerr SJ; Gruskin S; Pancharoen C; Ananworanich J, 2007, 'Antiretroviral therapy adherence did not differ between thai children with biological and those with nonbiological parents [7]', Clinical Infectious Diseases, 45, pp. 669 - 670, http://dx.doi.org/10.1086/520784

Baden LR; Marty FM, 2007, 'Posaconazole for invasive aspergillosis?', CLINICAL INFECTIOUS DISEASES, 45, pp. 664 - 664, http://dx.doi.org/10.1086/519510

Kerr SJ; Duncombe CJ; Avihingsanon A; Ananworanich J; Boyd MA; Sopa B; Chuenyam T; Cooper DA; Lange JM; Phanuphak P; Ruxrungtham K, 2007, 'Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.', Journal of the International Association of Physicians in AIDS Care, 6, pp. 36 - 46

Boom J; Kosters E; Duncombe CJ; Kerr SJ; Hirschel B; Ruxrungtham K; de Mast Q; Kosalaraksa P; Ulbolyam S; Jupimai T; Ananworanich J, 2007, 'Ferritin levels during structured treatment interruption of highly active antiretroviral therapy.', HIV Medicine, 8, pp. 388 - 395

Vemula S; Kerr SJ; Pancharoen C; Siripong A; Kosalaraksa P; Engchanil C; Chuamchaitrakool A; Intasan J; Lumbiganond P; Phanuphak P; Ananworanich J, 2007, 'Incidence and risk factors for non-nucleoside reverse transcriptase inhibitors (NNRTI)-related rash in Thai children with HIV infection.', Journal of the Medical Association of Thailand, 90, pp. 2437 - 2441

Kerr SJ; Lange J; Cooper DA; Phanupak P; Ruxrungtham K, 2006, 'HIV-NAT Promoting Rational and Evidence-based Use of Antiretroviral Therapies', Asia-Pacific Biotech News, 10, pp. 1229 - 1234, http://dx.doi.org/10.1142/s0219030306001820

Avihingsanon A; Avihingsanon Y; Darnpornprasert P; Kerr SJ; Ungsedhapand C; Duncombe CJ; Ubolyam S; Ruxrungtham K; Phanuphak P, 2006, 'High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.', Journal of the Medical Association of Thailand, 89, pp. S21 - S27

Duncombe CJ; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange J; Phanuphak P; Cooper DA, 2005, 'HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting', AIDS, 19, pp. 169 - 178

Glaser AN, 2004, 'Computer aided prescribing - Software needs to take account of how doctors prescribe', BRITISH MEDICAL JOURNAL, 328, pp. 1565 - 1565, http://dx.doi.org/10.1136/bmj.328.7455.1565-b

Glaser AN; Farrar K; Slee A; Hughes D; Marsh P; Makin C; Wong K; Tam P; Liaw ST; Kerr S, 2004, 'Computer aided prescribing [3] (multiple letters)', British Medical Journal, 328, pp. 1565 - 1566

Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GRP, 2004, 'Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners - Reply', MEDICAL JOURNAL OF AUSTRALIA, 180, pp. 311 - 311, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220468700022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Florin THJ; Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GP; Dowden JS, 2004, 'Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners (multiple letters) [4]', Medical Journal of Australia, 180, pp. 310 - 311, http://dx.doi.org/10.5694/j.1326-5377.2004.tb05938.x

Liaw ST; Kerr S, 2004, 'Computer aided prescribing: decision support needs to be evidence based.', BMJ Clinical Research Ed, 328, pp. 1566, http://dx.doi.org/10.1136/bmj.328.7455.1566-a

Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GP, 2004, 'Lessons from early large‐scale adoption of celecoxib and rofecoxib by Australian general practitioners', Medical Journal of Australia, 180, pp. 310 - 312, http://dx.doi.org/10.5694/j.1326-5377.2004.tb05939.x

Kerr SJ; Mant A; Horn FE; McGeechan K; Sayer GP, 2003, 'Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners', Medical Journal of Australia, 179, pp. 403 - 407, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05616.x

Ahearn MD; Kerr SJ, 2003, 'General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software', Medical Journal of Australia, 179, pp. 34 - 37, http://dx.doi.org/10.5694/j.1326-5377.2003.tb05415.x

Smythe GA; Braga O; Brew BJ; Grant RS; Guillemin GJ; Kerr SJ; Walker DW, 2002, 'Concurrent quantification of quinolinic, picolinic and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry', Analytical Biochemistry, 301, pp. 21 - 26

Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2001, 'IFN-b1b induces Kynurenine pathway metabolism in human macrophages:potential implications for multiple sclerosis treatment', Journal of Interferon and Cytokine Research, pp. 1097 - 1101

Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ, 2001, 'Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection', Journal of Neurochemistry, pp. 842 - 853

Smith DG; Guillemin GJ; Pemberton LA; Kerr SJ; Nath A; Smythe GA; Brew BJ, 2001, 'Quinolinic acid is produced by macrophages stimulated by platelet activating factor, NeF and Tat', Journal of Neurovirology, pp. 56 - 60

Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis', Redox Report, 5, pp. 108 - 111

Back to profile page